Oral HIV Self-Test Approved in Canada: A Major Step Toward Earlier Detection and Elimination

Canada has approved a new oral HIV self-test for sale — a development that public health experts say could play a critical role in earlier diagnosis, improved access to testing, and progress toward eliminating HIV as a public health threat by 2030.

How the Oral HIV Self-Test Works

The oral HIV self-test uses a flat swab that is gently passed along the upper and lower gums. The swab is then placed into a test cartridge, and results are available in about 20 minutes.

The test detects HIV antibodies present in oral fluid. A control line confirms the test is working properly, and a second line indicates a reactive (positive) result that requires confirmatory laboratory testing.

Large studies show that the oral test performs comparably to blood-based self-tests when used correctly.

Key advantages include:

• No finger prick required
• Less intimidating for needle-averse individuals
• Portable and private
• Fast results at home or in community settings
• Useful for outreach programs and underserved populations

Why This Matters for HIV Prevention in Canada

Recent Canadian data show that new HIV diagnoses rose from about 1,800 cases in 2022 to over 2,400 in 2023, with some decline reported in 2024. However, certain provinces — including Saskatchewan and Manitoba — continue to report rates several times higher than the national average.

Testing remains one of the most powerful tools in HIV prevention. People who know their status can:

• Start treatment earlier
• Reduce transmission risk
• Access preventive care and support
• Protect partners and family members

Experts emphasize that self-testing helps reach people who may avoid traditional clinics due to stigma, access barriers, cultural mistrust, or inconvenience.

Cost and Access Considerations

Current pricing estimates suggest:

• Blood-based self-tests: about $35
• New oral self-test: expected $15–$20

Some provinces have funded HIV self-testing programs, but national funding has been inconsistent. Public health leaders and community organizations continue to advocate for broader subsidized access, especially for higher-risk and underserved communities.

Why Pharmacist-Led Support Still Matters

While self-tests increase convenience, they are not a replacement for professional healthcare guidance.

At Centrum Pharmacy, pharmacist-led counselling remains essential for:

• Understanding when and how to test
• Interpreting results correctly
• Arranging confirmatory laboratory testing
• Connecting patients to treatment and care pathways
• Discussing prevention options such as PrEP and safer practices
• Addressing medication questions and drug interactions

This aligns with our Complete, Comprehensive, Caring, Connected Care (the 4 C’s) model — where testing is not just a transaction, but part of a coordinated care plan.

Integrated Care Through Our Physician Network

Centrum Pharmacy works closely with Orleans Family Health Clinic and our physician recruitment initiatives to improve primary care access for our community. When a patient needs follow-up after screening — whether for HIV, other infections, or chronic disease — we can help connect them with appropriate medical care more quickly than fragmented retail channels.

Better testing only improves outcomes when it is linked to real clinical follow-through — and that is where integrated pharmacy-clinic collaboration makes a measurable difference.

Bottom Line

The approval of an oral HIV self-test in Canada is a meaningful public health milestone. It reduces barriers, increases privacy, and expands testing reach. But the strongest outcomes will come when self-testing is paired with pharmacist counselling, confirmatory care, and connected primary care support.

If you have questions about HIV testing, prevention, or follow-up care, speak with a Centrum Pharmacy pharmacist. Confidential, evidence-based guidance is always available.